The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma

• Published in: Pathology, research and practice Vol. 216; no. 2; p. 152785
• Main Authors: Zhong, Feng, Lu, Hui-Ping, Chen, Gang, Dang, Yi-Wu, Li, Guo-Sheng, Chen, Xiao-Yi, Qin, Yong-Ying, Yao, Yu-Xuan, Zhang, Xiao-Guohui, Liang, Yao, Li, Ming-Xuan, Mo, Miao, Zhang, Kai-Lang, Ding, Hua, Huang, Zhi-Guang, Wei, Zhu-Xin
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.02.2020
• Subjects: Carcinoma, Squamous Cell - genetics; Carcinoma, Squamous Cell - metabolism; Carcinoma, Squamous Cell - pathology; Female; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Immunohistochemistry; Integrin beta4 - genetics; Integrin beta4 - metabolism; Integrin subunit beta 4; Laryngeal Neoplasms - genetics; Laryngeal Neoplasms - metabolism; Laryngeal Neoplasms - pathology; Larynx; Larynx - pathology; Male; Microarray; Microarray Analysis; Middle Aged; Protein Interaction Mapping; RNA-sequencing; Sequence Analysis, RNA; Signal Transduction; Squamous cell carcinoma; Immunohistochemistry; RNA-sequencing; Squamous cell carcinoma; Larynx; Integrin subunit beta 4; Microarray
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2019.152785

The relationship between integrin beta 4 (ITGB4) expression and laryngeal squamous cell carcinoma (LSCC) remains unclarified. The object of the present study was to explore the clinical significance and potential molecular mechanism of ITGB4 in LSCC. The protein level of ITGB4 was significantly higher in 46 LSCC patients than in 26 non-LSCC tissues detected by in-house immunohistochemistry. Consistently, ITGB4 mRNA level was also greatly upregulated based on microarray and RNA-seq data (standard mean difference, SMD = 1.62, 95 % CI: 1.23–2.00). And the area under curves (AUC) of summary receiver operator characteristic (SROC) was 0.87 (95 % CI: 0.84–0.90) based on 172 cases of LSCC and 59 cases of non-cancerous controls. Ninety genes were intersected by the ITGB4 related genes and LSCC differential expressed genes (DEGs) from all available microarray and RNA-seq datasets. Based on Gene Ontology (GO) analysis, the top terms of biological process (BP), cellular component (CC) and molecular function (MF) for the 90 ITGB4 related DEGs were extracellular matrix organization, basement membrane and extracellular matrix structural constituent, respectively. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis showed that ITGB4 related DEGs mainly participated in the pathways of ECM-receptor interaction, Focal adhesion and Small cell lung cancer. Moreover, the Protein-Protein Interaction (PPI) network indicated that ITGA3, ITGA5, ITGB4, MET, LAMA3, and COL4A1 might be the core genes of LSCC development related to ITGB4. In conclusion, high ITGB4 expression may lead to the occurrence and development of LSCC via various signaling pathways.